Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation (Details Textual)

v2.4.0.6
Stockholders' Equity and Share-Based Compensation (Details Textual) (USD $)
3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 9 Months Ended 6 Months Ended 9 Months Ended 9 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Sep. 29, 2012
Oct. 01, 2011
Dec. 31, 2011
Sep. 29, 2012
Performance Shares [Member]
Mar. 31, 2012
Warrants [Member]
Jun. 30, 2012
Warrants [Member]
Sep. 29, 2012
Warrants [Member]
Oct. 01, 2011
Warrants [Member]
Apr. 27, 2010
Warrants [Member]
May 05, 2009
Warrants [Member]
Sep. 29, 2012
2007 Omnibus Plan [Member]
Dec. 31, 2011
2007 Omnibus Plan [Member]
Jun. 30, 2012
2007 New Employee Incentive Plan [Member]
Sep. 29, 2012
2007 New Employee Incentive Plan [Member]
Dec. 31, 2011
2007 New Employee Incentive Plan [Member]
Sep. 29, 2012
2007 New Employee Incentive Plan [Member]
Stock Option [Member]
Sep. 29, 2012
2006 Equity Incentive Plan [Member]
Jun. 30, 2012
2006 Equity Incentive Plan [Member]
Sep. 29, 2012
Board of Directors [Member]
2007 Omnibus Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                          
Common stock authorized from stock option exercises 100,000,000   100,000,000   100,000,000                                
Common stock authorized                                   2,000,000      
Common stock issued 31,125,000   31,125,000   30,626,000                               10,121
Shares of common stock issued from option exercise     489,105                   (55,772)     (433,333)          
Equity value of issued stock awards $ 159,446,000   $ 159,446,000   $ 157,140,000               $ 42,500                
Option grant expiry date                               Oct. 31, 2007          
Option grant vesting period                         4 years   4 years            
Exercise price of option grants                         100.00%     100.00%          
Shares available for future grants                         1,857,241     781,667     0    
Weighted-average fair value of options granted                         $ 2.65     $ 2.72          
Options outstanding                         5,988,943 5,526,090   785,000 1,250,000   672,000    
Intrinsic value of the exercised options                         1,100,000     100,000          
Options exercisable                         4,101,202     750,000       672,000  
Option expired                                     6,600    
Performance options to purchase shares of common stock     125,000                                    
Unrecognized share-based compensation expense 3,000,000   3,000,000                   2,400,000     47,000          
Weighted-average period of unrecognized share-based compensation expense     2 years 8 months 12 days                   2 years 8 months 12 days                
Common stock warrants issued during period                     20,000 30,000                  
Warrant exercise price for warrants issued during period                     8.32 2.14                  
Increment of shares in warrant vest                     833 833                  
Grant date fair value of warrants issued during period                     $ 2.12 $ 1.09                  
Remeasured fair value of warrants               $ 3.14                          
Warrants exercised during period                 0                        
Outstanding common stock warrants                 50,000                        
Aggregate intrinsic value of outstanding and exercisable warrants                 39,600                        
Share-based compensation expense recognized related to warrants 0 12,000             16,000 55,000                      
Share-based compensation expenses reversed during period           105,000                              
Unrecognized share-based compensation expense related to warrants outstanding                 0                        
Fully vested warrants             $ 1.42                            
Common stock authorized from stock option exercises 100,000,000   100,000,000   100,000,000                                
Estimated forfeitures excluded from unrecognized share-based compensation expense     2,400,000                                    
Amounts capitalized to internally-developed software 56,000 60,000 192,000 171,000                                  
Performance stock option adjustment     $ 94,000